Konstance Knox

Konstance K. Knox
Born (1955-10-14) October 14, 1955 (age 69)
Wisconsin, US
Alma materMarquette (BS; Medical Laboratory Sciences 1977), Cardinal Stritch (MA; Business Management 1990), Medical College of Wisconsin(PhD; Experimental Pathology 1994), St. Luke's Medical Center Milwaukee(Post Doctoral Fellowship)
Known forCo-founder Viracor.,[1][2][3] Early work on multiple sclerosis.[2]
Scientific career
FieldsVirology, Laboratory Economics, Biotechnology Entrepreneur

Konstance K. Knox (born October 14, 1955) is an American virologist and entrepreneur who founded Coppe Laboratories,[4] Viracor,[1][2][3] the Wisconsin Viral Research Group (WVRG)[5][6] and Viracor's Institute for Viral Pathogenesis (IVP).[2][7] In 2000, Viracor became the first biotechnology company in the United States to correlate multiple sclerosis with human herpesvirus 6 (HHV-6).[2][8]

  1. ^ a b Robert Huntington. "A giant leap for ME research!". National CFIDS Foundation.
  2. ^ a b c d e Joe Manning (November 10, 2000). "Wauwatosa lab links virus to MS - Small study finds signs of herpes in lesions". Journal-Sentinel. Milwaukee. Archived from the original on 2001-03-06. First to correlate HHV-6 to MS.
  3. ^ a b "List of graduates and past tenants" (PDF). Milwaukee County Research Park. Archived from the original (PDF) on 2008-07-24.
  4. ^ "About Coppe Laboratories". Coppe Laboratories. Retrieved 2023-12-28.
  5. ^ Julie Steenhuysen (May 31, 2011). "Mouse virus doesn't cause chronic fatigue: reports". Reuters.
  6. ^ "Murine viruses not linked to human infection". MD News. June 1, 2011. Archived from the original on April 24, 2012.
  7. ^ "Mult sclerosis".
  8. ^ Knox KK; Brewer JH; Henry, James M.; Harrington, Daniel J.; Carrigan, Donald R. (2000). "Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease". Clin Infect Dis. 31 (4): 894–903. doi:10.1086/318141. PMID 11049767.